ABEC buys Ireland plant to make bioprocessing equipment in Europe

By Dan Stanton contact

- Last updated on GMT

Related tags: Bristol-myers squibb

Fermoy, County Cork to be ABEC's new EU headquarters
Fermoy, County Cork to be ABEC's new EU headquarters
Bioprocess equipment maker ABEC has bought an ex-electronic component facility in Ireland in order to gain greater access to the European market.

ABEC makes processing equipment for biomanufacturers and the Bethlehem, Pennsylvania-based firm has announced this week it is acquiring a facility in Fermoy, County Cork.

The 87,000sq ft site and the surrounding land was previously owned by French firm FCI, with the facility making electronic components for the automative industry but the acquisition will see it produce “custom engineered process equipment for the clinical and commercial manufacturing of biopharmaceuticals,” ​according to spokesperson Emily Smith.

“Similar to our US HQ, we will be able to engineer, design, manufacture, and test the entire bioprocess – upstream, downstream, and clean utilities,”​ she told Biopharma-Reporter.com. “We will also provide comprehensive site services from this site.”

Smith could not disclose financial details of the deal, but did say transforming the facility into a bioprocessing equipment plant would not be a problem.

“The FCI facility is nicely set up for making our products. We will only need to retrofit utilities for equipment testing, install overhead cranes, and do various smaller upgrades.”

Ireland

ABEC ranks the majority of the world’s biomanufacturers among its customers, but the acquisition of this facility will keep the firm “ahead of the growth.”

Furthermore, the site will form ABEC’s European headquarters and, according to Smith, the location will make use of Ireland’s talent pool and training, as well as grant the firm access to the broader European market.

News of the acquisition and the creation of over 100 jobs was welcomed by Ireland’s Industrial Development Authority.

Ireland has become a hub of biomanufacturing over the past few years, with recent large investments from companies such as Pfizer​, Bristol-Myers Squibb, Regeneron and Eli Lilly​.

Related news

Show more

Related products

show more

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Custom manufacturing of protease inhibitor PMSF

Custom manufacturing of protease inhibitor PMSF

Actylis – The Partner of Choice | 09-Nov-2022 | Technical / White Paper

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...

Related suppliers

Follow us

Products

View more

Webinars